4//SEC Filing
Bell Graeme 4
Accession 0001209191-18-022178
CIK 0001652130other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 10:20 AM ET
Size
7.1 KB
Accession
0001209191-18-022178
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-03-28$13.48/sh+8,000$107,840→ 21,400 total - Exercise/Conversion
Stock Option (Right to buy)
2018-03-28−8,000→ 202,000 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]On January 3, 2017, the Reporting Person was granted an option to purchase 210,000 common shares under the company's 2015 Amended and Restated Stock Option and Incentive Plan. The shares reported as being purchased in this Form 4 were fully vested and exercisable as of the transaction date.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001643757
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 10:20 AM ET
- Size
- 7.1 KB